Articles Tagged With: COVID-19
-
Two Possible Mechanisms of Disease in COVID-19
COVID-19 infection may be associated with an increased risk of blood clotting and related thrombotic events, but there are insufficient data to support indiscriminately discontinuing medications that play a critical role in the management of chronic cardiovascular disease.
-
Biometrics Expert Discusses Data Integrity for COVID-19 Clinical Trials
The first remdesivir double-blind, placebo-controlled clinical trial for treating COVID-19 was published recently in Lancet. A member of the trial’s data safety monitoring board is Weichung Shih, PhD. Shih discussed the role of biostatisticians in protecting data integrity for clinical trials and the challenges during the COVID-19 pandemic.
-
Vaccine Challenge Trials Present Ethical Issues to IRBs, HRPPs
Bioethicists and researchers say it may be possible to shorten the typical 15-year-plus vaccine timeline through a challenge trial. In this model, participants receive the study vaccine, the are deliberately exposed to SARS-CoV-2. Safety and efficacy are important, but the risk-benefit balance for study participants is weighed more heavily in favor of the greater public good.
-
COVID-19: Pandemic 2020
Coronavirus disease 2019 (COVID-19) is a rapidly spreading disease, and our knowledge is rapidly growing.
-
Senators Call for Permanent Expansion of Telehealth
The service has become incredibly popular and useful during the COVID-19 pandemic.
-
OSHA Enforcement Prioritizing Hazards Related to COVID-19 Response
The Occupational Safety and Health Administration has vowed to take a hard look at complaints and referrals related to employee safety during the COVID-19 pandemic. Healthcare employers should prepare to answer concerns about employee safety.
-
Many Hospitals Lacked Ventilator Triage Policies When COVID-19 Pandemic Hit
More than half of institutions did not have ventilator triage policies in place when the pandemic arrived, according to the authors of a study.
-
Compliance Oversight Necessary with COVID-19 Relief Funds
Funds provided to hospitals through the Coronavirus Aid, Relief, and Economic Security Act require careful compliance efforts to avoid substantial liability. The money comes with many strings attached.
-
Some Attorneys Vow Not to Sue Over COVID-19 Care
Risk managers are bracing for what some fear will be a wave of malpractice claims related to COVID-19 care. However, some attorneys say they will not take these cases, arguing the treatment standard is unclear, and substandard care claims cannot be substantiated.
-
Remdesivir and COVID-19
Remdesivir is safe and moderately effective in the treatment of patients with COVID-19.